Paper33520751
Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis.
Ramstad E and 13 others. Scand J Child Adolesc Psychiatr Psychol, 2018. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis. Papers, record 33520751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33520751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25885010 | Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response. | J Child Adolesc Psychopharmacol | 2015 | https://conductscience.org/library/papers/25885010 | PubMed |
| 2 | 21871372 | Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. | J Am Acad Child Adolesc Psychiatry | 2011 | https://conductscience.org/library/papers/21871372 | PubMed |
| 3 | 26719291 | Stimulant Medication and Psychotic Symptoms in Offspring of Parents With Mental Illness. | Pediatrics | 2016 | https://conductscience.org/library/papers/26719291 | PubMed |
| 4 | 25416419 | Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. | BMC Med Res Methodol | 2014 | https://conductscience.org/library/papers/25416419 | PubMed |
| 5 | 17581453 | Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. | J Am Acad Child Adolesc Psychiatry | 2007 | https://conductscience.org/library/papers/17581453 | PubMed |
| 6 | 19587853 | Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate. | Curr Neuropharmacol | 2008 | https://conductscience.org/library/papers/19587853 | PubMed |
| 7 | 26267421 | Remission Rate and Functional Outcomes During a 6-Month Treatment With Osmotic-Release Oral-System Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder. | J Clin Psychopharmacol | 2015 | https://conductscience.org/library/papers/26267421 | PubMed |
| 8 | 23312392 | GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. | J Clin Epidemiol | 2013 | https://conductscience.org/library/papers/23312392 | PubMed |
| 9 | 29744873 | Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29744873 | PubMed |
| 10 | 10585981 | A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder. | Pediatrics | 1999 | https://conductscience.org/library/papers/10585981 | PubMed |
| 11 | 19622552 | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. | BMJ | 2009 | https://conductscience.org/library/papers/19622552 | PubMed |
| 12 | 18942172 | Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. | Ann Intern Med | 2008 | https://conductscience.org/library/papers/18942172 | PubMed |
| 13 | 19621072 | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. | PLoS Med | 2009 | https://conductscience.org/library/papers/19621072 | PubMed |
| 14 | 18294084 | Cognitive and behavioral effects of multilayer-release methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder. | J Child Adolesc Psychopharmacol | 2008 | https://conductscience.org/library/papers/18294084 | PubMed |
| 15 | 19502578 | Methylphenidate induction of complex visual hallucinations. | J Child Neurol | 2009 | https://conductscience.org/library/papers/19502578 | PubMed |
| 16 | 18083463 | Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. | J Clin Epidemiol | 2008 | https://conductscience.org/library/papers/18083463 | PubMed |
| 17 | 21497704 | Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. | Clin Ther | 2011 | https://conductscience.org/library/papers/21497704 | PubMed |
| 18 | 26363968 | Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan. | Schizophr Res | 2015 | https://conductscience.org/library/papers/26363968 | PubMed |
| 19 | 17541055 | The worldwide prevalence of ADHD: a systematic review and metaregression analysis. | Am J Psychiatry | 2007 | https://conductscience.org/library/papers/17541055 | PubMed |
| 20 | 26608309 | Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. | BMJ | 2015 | https://conductscience.org/library/papers/26608309 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42847833 | Investigating Potential Adverse Drug Reactions of Lisdexamfetamine Using Sequence Symmetry Analysis. | Basic Clin Pharmacol Toxicol | 2026 | https://conductscience.org/library/papers/42847833 | PubMed |
| 42656627 | Disproportionality analysis of methylphenidate-associated adverse events in pediatric patients using the FDA Adverse Event Reporting System: overall signals and stratification by gender and dosage form. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42656627 | PubMed |
| 41916954 | Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort study. | Transl Psychiatry | 2026 | https://conductscience.org/library/papers/41916954 | PubMed |
| 41879751 | Methylphenidate Treatment and Risk of Psychotic Disorder. | JAMA Psychiatry | 2026 | https://conductscience.org/library/papers/41879751 | PubMed |
| 40422911 | Gut-Brain Inflammatory Pathways in Attention-Deficit/Hyperactivity Disorder: The Role and Therapeutic Potential of Diet. | Metabolites | 2025 | https://conductscience.org/library/papers/40422911 | PubMed |
| 39583637 | Comparison of the real-world safety of two different long-acting methylphenidate formulations (Medikinet® MR and Concerta®) - a Danish nationwide register-based cohort study. | Scand J Child Adolesc Psychiatr Psychol | 2024 | https://conductscience.org/library/papers/39583637 | PubMed |
| 38609318 | Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults. | BMJ Ment Health | 2024 | https://conductscience.org/library/papers/38609318 | PubMed |
| 37585250 | The Adverse Effects and Nonmedical Use of Methylphenidate Before and After the Outbreak of COVID-19: Machine Learning Analysis. | J Med Internet Res | 2023 | https://conductscience.org/library/papers/37585250 | PubMed |
| 36860219 | Psychosis Induced by Methylphenidate in Children and Young Patients With Attention-Deficit Hyperactivity Disorder. | Cureus | 2023 | https://conductscience.org/library/papers/36860219 | PubMed |
| 34449694 | Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder? | Pediatr Rep | 2021 | https://conductscience.org/library/papers/34449694 | PubMed |
| 33520746 | Occurrence of psychotic symptoms during treatment of ADHD with methylphenidate: Clinical significance and the need for further research. | Scand J Child Adolesc Psychiatr Psychol | 2018 | https://conductscience.org/library/papers/33520746 | PubMed |
| 31221557 | Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study. | Lancet Psychiatry | 2019 | https://conductscience.org/library/papers/31221557 | PubMed |
| 29744873 | Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29744873 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SNAP25 | 6616 | PubTator's text mining | https://conductscience.org/library/genes/6616 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33520751
GET https://conductscience.org/api/papers/v1/33520751/references?page=2